You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 18, November 12, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Neurology
 •Cardiovascular Interventions, Other
 •Cerebrovascular Disease
 •Cardiovascular System, Other
 •Stroke
 •Cardiovascular System
 •Surgery
 •Surgical Interventions
 •Vascular Surgery
 •Drug Therapy
 •Drug Therapy, Other
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In his Clinical Crossroads article, Dr Caplan1 discussed a 70-year-old man with coronary, aortic, and peripheral arterial disease who had an episode of brain ischemia caused by severe preocclusive internal carotid disease. Caplan recommended treatment with a high dose of statin (atorvastatin, 80 mg daily). However, this is based on extrapolation from studies of younger patients and does not consider adverse effects.

A secondary analysis of the Treating to New Target (TNT) study compared the outcomes of 10 mg vs 80 mg of atorvastatin daily in patients aged 65 to 75 years with stable coronary heart disease.2 Despite participant selection and an open-label run-in phase that excluded patients with concomitant medical conditions that might increase the risk of statin-related adverse effects, this study found that with the higher dose of statin the absolute reduction of major fatal or nonfatal cardiovascular events (2.3%) was lower than the increase . . . [Full Text of this Article]

Luca Mascitelli, MD
lumasci@libero.it
Medical Service
Comando Brigata Alpina "Julia"
Udine, Italy

Francesca Pezzetta, MD
Cardiology Service
Ospedale di Tolmezzo
Tolmezzo, Italy

Mark R. Goldstein, MD
Fountain Medical Court
Bonita Springs, Florida



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLES

Carotid Endarterectomy as the Criterion Standard in High-Risk Elderly Patients
Ahmed Suliman, Joshua Greenberg, Ankur Chandra, Samuel Barillas, Pooya Iranpour, and Niren Angle
Arch Surg. 2008;143(8):736-742.
ABSTRACT | FULL TEXT  

A 70-Year-Old Man With a Transient Ischemic Attack: Review of Internal Carotid Artery Stenosis
Louis R. Caplan
JAMA. 2008;300(1):81-90.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease
John R. Kapoor
JAMA. 2008;300(18):2117-2118.
EXTRACT | FULL TEXT  

Carotid Endarterectomy and Statin Therapy in the Management of Patients With Carotid Artery Disease—Reply
Louis R. Caplan
JAMA. 2008;300(18):2119.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.